Towards Development of Small Molecule Lipid II Inhibitors as Novel Antibiotics.
Recently we described a novel di-benzene-pyrylium-indolene (BAS00127538) inhibitor of Lipid II. BAS00127538 (1-Methyl-2,4-diphenyl-6-((1E,3E)-3-(1,3,3-trimethylindolin-2-ylidene)prop-1-en-1-yl)pyryl-1-ium) tetrafluoroborate is the first small molecule Lipid II inhibitor and is structurally distinct...
Main Authors: | Jamal Chauhan, Steven Cardinale, Lei Fang, Jing Huang, Steven M Kwasny, M Ross Pennington, Kelly Basi, Robert diTargiani, Benedict R Capacio, Alexander D MacKerell, Timothy J Opperman, Steven Fletcher, Erik P H de Leeuw |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5077133?pdf=render |
Similar Items
-
Structure–activity exploration of a small-molecule Lipid II inhibitor
by: Fletcher S, et al.
Published: (2015-04-01) -
Optimization of a Benzothiazole Indolene Scaffold Targeting Bacterial Cell Wall Assembly
by: Chauhan J, et al.
Published: (2020-02-01) -
Computational fragment-based binding site identification by ligand competitive saturation.
by: Olgun Guvench, et al.
Published: (2009-07-01) -
Characterization of Mg2+ Distributions around RNA in Solution
by: Justin A. Lemkul, et al.
Published: (2016-10-01) -
Conformational Heterogeneity of the HIV Envelope Glycan Shield
by: Mingjun Yang, et al.
Published: (2017-06-01)